Akebia Therapeutics
AKBA
#8265
Rank
HK$2.12 B
Marketcap
HK$7.91
Share price
-0.98%
Change (1 day)
-64.02%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: HK$2.12 Billion

As of May 2026 Akebia Therapeutics has a market cap of HK$2.12 Billion. This makes Akebia Therapeutics the world's 8265th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.12 B-38.06%
2025HK$3.42 B3.77%
2024HK$3.30 B81.04%
2023HK$1.82 B119.99%
2022HK$0.82 B-73.1%
2021HK$3.08 B-1.73%
2020HK$3.13 B-47.61%
2019HK$5.98 B18.32%
2018HK$5.06 B-7.83%
2017HK$5.49 B77.51%
2016HK$3.09 B0.76%
2015HK$3.07 B66.95%
2014HK$1.83 B

End of Day market cap according to different sources

On May 21st, 2026 the market cap of Akebia Therapeutics was reported to be:

HK$2.14 Billion
by Nasdaq info icon info icon
HK$2.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.431 T 208,618.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.275 T 107,072.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$1.434 T 67,453.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$17.75 B 736.12%๐Ÿ‡บ๐Ÿ‡ธ USA